This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1980;22(1):1-5.

The binding of platelet-activating factor (PAF) to polymorphonuclear neutrophils (PMN) as a trigger for the immune-induced PMN aggregation

G Camussi, F Bussolino, C Tetta, R Brusca, R Ragni

PMID: 7413229

The binding of platelet-activating factor (PAF) to polymorphonuclear neutrophils (PMN) as a trigger for the immune-induced PMN aggregation

G Camussi et al. Panminerva Med. 1980.

. 1980;22(1):1-5.

Authors

G Camussi, F Bussolino, C Tetta, R Brusca, R Ragni

PMID: 7413229

No abstract available

PubMed Disclaimer

Similar articles

Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils.
Camussi G, Aglietta M, Coda R, Bussolino F, Piacibello W, Tetta C. Camussi G, et al. Immunology. 1981 Feb;42(2):191-9. Immunology. 1981. PMID: 6161885 Free PMC article.
Platelet activating factor: an inhibitor of neutrophil activation?
O'Donnell MC, Siegel JN, Fiedel BA. O'Donnell MC, et al. Clin Exp Immunol. 1981 Jan;43(1):135-42. Clin Exp Immunol. 1981. PMID: 7249391 Free PMC article.
Immune-induced leucopenia. A role for the aggregation of polymorphonuclear neutrophils in systemic lupus erythematosus (SLE).
Camussi G, Segoloni G, Tetta C, Bussolino F, Stratta P, Ragni R, Vercellone A. Camussi G, et al. Minerva Nefrol. 1981 Jul-Sep;28(3):221-3. Minerva Nefrol. 1981. PMID: 7329598 No abstract available.
Role of polymorphonuclear leukocytes in the vascular responses of acute inflammation.
Issekutz AC. Issekutz AC. Lab Invest. 1984 Jun;50(6):605-7. Lab Invest. 1984. PMID: 6374283 Review. No abstract available.
[Recent information on PAF (Platelet Activating Factor) in hemocoagulative and immuno-allergic processes].
Modiano A, Belisario A. Modiano A, et al. G Clin Med. 1982 Sep;63(9):591-4. G Clin Med. 1982. PMID: 6762313 Review. Italian. No abstract available.

See all similar articles

Cited by

Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia.
Camussi G, Bussolino F, Tetta C, Caligaris Cappio F, Coda R, Macchiorlatti E, Alberton M, Roffinello C, Segoloni G. Camussi G, et al. Immunology. 1983 Apr;48(4):625-33. Immunology. 1983. PMID: 6339375 Free PMC article.
Biology and biochemistry of platelet-activating factor.
O'Flaherty JT, Wykle RL. O'Flaherty JT, et al. Clin Rev Allergy. 1983 Sep;1(3):353-67. doi: 10.1007/BF02991226. Clin Rev Allergy. 1983. PMID: 6370406 Review. No abstract available.
Tierexperimentelle untersuchungen zur rolle von entzündungsmediatoren bei der hornhautneovaskularisation.
Rochels R. Rochels R. Doc Ophthalmol. 1984 May;57(3):215-262. doi: 10.1007/BF00143085. Doc Ophthalmol. 1984. PMID: 28063026 German.
Role of extracellular calcium and neutrophil degranulation responses to 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine.
O'Flaherty JT, Swendsen CL, Lees CJ, McCall CE. O'Flaherty JT, et al. Am J Pathol. 1981 Nov;105(2):107-13. Am J Pathol. 1981. PMID: 6271016 Free PMC article.
Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2).
Camussi G, Tetta C, Segoloni G, Chiara Deregibus M, Bussolino F. Camussi G, et al. Agents Actions. 1981 Dec;11(6-7):550-3. doi: 10.1007/BF01978735. Agents Actions. 1981. PMID: 7041569

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions